デジタル医薬品サプライチェーン管理市場- 世界の産業規模、シェア、動向、機会、予測、製品別、提供形態別、ソフトウェアモジュール別、地域別、競合別、2019年～2029年

世界のデジタル医薬品サプライチェーン管理市場の2023年の市場規模は8億9,021万米ドルで、2029年までのCAGRは6.64%で、予測期間中に目覚ましい成長を遂げると予測されています。

この分野のデジタル化には、ブロックチェーン、IoT（モノのインターネット）、AI（人工知能）、クラウドコンピューティング、データ分析などの技術の統合が含まれ、業務の合理化、透明性の向上、効率の改善が図られます。

世界のデジタル医薬品サプライチェーン管理市場は、偽造医薬品と闘い、製品の真正性と安全性を確保する必要性が、追跡追跡機能のためにブロックチェーンのようなデジタル技術を導入する重要な促進要因となっています。規制機関が課す厳しい規制は、医薬品サプライチェーンにおけるトレーサビリティと透明性の向上を必要とし、デジタルソリューションの採用を促進しています。製薬会社は、コスト削減と業務効率向上のため、サプライチェーンプロセスの最適化を迫られています。デジタルソリューションは、リアルタイムの可視性、予測分析、自動化を提供し、これらの目標を達成します。患者中心のヘルスケアへの注目が高まっており、在庫管理の改善、個別化医療、医薬品の迅速な配送が求められています。デジタル・サプライチェーン・ソリューションは、より優れた在庫追跡と個別サービスを可能にします。

主な市場促進要因

新しいエンド・ツー・エンドのサプライチェーン管理

運用ツールの増加

デジタル革新

データ分析の重要性の高まり

主な市場課題

データのセキュリティとプライバシー

製品のトレーサビリティ

相互運用性

主な市場動向

オンライン薬局の急増

需要予測の改善

ブロックチェーン技術

セグメント別洞察

製品別洞察

提供形態別洞察

地域別洞察

目次

第1章 サービス概要

• 市場の定義
• 市場の範囲
  • 対象市場
  • 調査対象年
  • 主要市場セグメンテーション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 デジタル医薬品サプライチェーン管理の世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別（ソフトウェア、ハードウェア）
  • 提供形態別（オンプレミス、クラウドベース、ウェブベース）
  • ソフトウェアモジュール別（計画分析、調達、製造、物流、在庫管理）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 北米のデジタル医薬品サプライチェーン管理市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 提供形態別
  • ソフトウェアモジュール別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のデジタル医薬品サプライチェーン管理市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 提供形態別
  • ソフトウェアモジュール別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のデジタル医薬品サプライチェーン管理市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 提供形態別
  • ソフトウェアモジュール別
  • 国別
• アジア太平洋地域国別分析
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 中国

第9章 南米のデジタル医薬品サプライチェーン管理市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 提供形態別
  • ソフトウェアモジュール別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのデジタル医薬品サプライチェーン管理市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 提供形態別
  • ソフトウェアモジュール別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の開発（もしあれば）
• M&A（あれば）
• 製品/サービスの発表（あれば）

第13章 デジタル医薬品サプライチェーン管理の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• McKesson Corporation
• Mediceo Corporation.
• Palantir Technologies, Inc
• InterSystems Corporation
• Tecsys Inc.
• Oracle Corporation
• SAP SE
• Infor Inc.
• CenTrak Inc.（HALMA plc）
• Terso Solutions, Inc.（Promega Corporation）

第16章 戦略的提言

第17章 免責事項

Global Digital Pharmaceutical Supply Chain Management Market was valued at USD 890.21 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.64% through 2029.The pharmaceutical supply chain involves the process of managing the flow of pharmaceutical products from manufacturing to distribution to patients. Digitalization in this sector involves the integration of technologies such as blockchain, IoT (Internet of Things), AI (Artificial Intelligence), cloud computing, and data analytics to streamline operations, enhance transparency, and improve efficiency.

The global digital pharmaceutical supply chain management market is driven by the need to combat counterfeit drugs and ensure product authenticity and safety is a significant driver for implementing digital technologies like blockchain for track-and-trace capabilities. Stringent regulations imposed by regulatory bodies necessitate better traceability and transparency in the pharmaceutical supply chain, driving the adoption of digital solutions. Pharmaceutical companies are under pressure to optimize their supply chain processes to reduce costs and improve operational efficiency. Digital solutions offer real-time visibility, predictive analytics, and automation to achieve these objectives. There's a growing focus on patient-centric healthcare, which requires improved inventory management, personalized medicine, and faster delivery of medications. Digital supply chain solutions enable better inventory tracking and personalized services.

Key Market Drivers

New End to End Supply Chain Management

The core of the pharma supply chain is raw material sourcing. This is where a manufacturer connects and coordinates with thousands of different suppliers to source multiple raw materials as well as Active pharmaceutical ingredients (APIs). Manually coordinating with these suppliers on such a large scale is not possible. Digital solutions here allow manufacturers to streamline the process with sophisticated dashboards and real time monitoring. This means they can view and store supplier data, perform risk analysis, manage quotations, quality control, etc. all in one place, allowing for efficient vendor management on a large scale. Transitioning from supplier to partner with the help of digital technology, real time stock sharing, real time forecast, and real time collaboration on market requirements is what the Pharma Industry needs most right now.

Digital enablement of the supply chain brings transparency across stakeholders and partners. With an integrated approach to supply chain, build a connected platform, and you can have a connected supply chain, where in supplier, manufacturer, distributor, and consumer are always aligned to act proactively. Decision making is the most important part of any business value chain. In the pharmaceutical industry, most of the leadership time and market share is spent on decision making. In today's highly competitive business environment, data-driven decision-making is essential for operational success. Pharmaceutical companies use a mix of solutions for each function, such as sourcing, manufacturing, Quality control, distribution, and more. Each function has its own dedicated tools that work in coordination to get better actionable insights. Thus, advanced end to end supply chain management helps in better decision making. This factor will accelerate the growth of global digital pharmaceutical supply chain management market.

Increase in Operational Tools

One of the most important components of the supply chain is a high-performing manufacturing process that maximizes efficiency and minimizes wastage. Digitalization and automation plays an important part in achieving operational excellence. Digitization refers to the use of cloud computing, analytics, and mobile devices to improve your operations. Digitization is changing the supply chain. From real-time inventory tracking via Internet of Things (IoT) sensors to automated warehouses and RPA (Robotic Process Automation) to automate processes and minimize mistakes. Manual errors and delays can be minimized and real-time insights into manufacturing operations can be gained by automating the manufacturing processes using different kinds of software solutions. Using data analytics and artificial intelligence (AI), supply chain managers can better forecast demand, manage inventory, and optimize operations throughout the supply chain.

Digital Innovation

The global demand for digital pharmaceutical supply chain management is experiencing a significant surge, propelled by the transformative impact of digital innovation. The pharmaceutical industry is undergoing a paradigm shift as it embraces digital technologies to enhance efficiency, visibility, and overall supply chain performance. Digital innovations such as blockchain, Internet of Things (IoT), real-time tracking, and data analytics are revolutionizing how pharmaceutical supply chains operate.

The adoption of digital solutions in pharmaceutical supply chain management addresses challenges related to traceability, counterfeit drugs, and regulatory compliance. Blockchain, for instance, ensures secure and transparent transactions, reducing the risk of counterfeit medications. IoT devices provide real-time monitoring of product conditions during transportation and storage, ensuring the integrity of pharmaceuticals. Data analytics enable predictive insights, optimizing inventory management and minimizing disruptions.

The global market response underscores the industry's recognition of the value proposition offered by digital innovation in pharmaceutical supply chain management. As companies prioritize digital transformations to stay competitive, the demand for digital solutions is poised to expand, marking a new era where technology plays a pivotal role in shaping the efficiency and resilience of pharmaceutical supply chains on a global scale.

Growing Importance of Data Analysis

The global demand for Digital Pharmaceutical Supply Chain Management is witnessing a robust increase, driven by the growing importance of data analysis within the pharmaceutical industry. As the volume and complexity of data generated in the supply chain continue to rise, leveraging advanced analytics has become essential for optimizing operations and decision-making processes. Digital solutions enable pharmaceutical companies to collect, process, and analyze vast amounts of data in real-time, offering insights into various facets of the supply chain, including inventory management, demand forecasting, and logistics optimization.

The emphasis on data analysis within digital pharmaceutical supply chain management is instrumental in enhancing efficiency, reducing costs, and ensuring regulatory compliance. Companies are increasingly recognizing the value of actionable insights derived from data to improve overall supply chain performance and respond swiftly to market dynamics.

Key Market Challenges

Data Security and Privacy

The global demand for Digital Pharmaceutical Supply Chain Management is facing a decline, primarily due to concerns surrounding data security and privacy. In an era where digital solutions play a pivotal role in supply chain optimization, pharmaceutical companies are grappling with the imperative to safeguard sensitive information. The intricate nature of pharmaceutical supply chains involves the exchange of confidential data among various stakeholders, including manufacturers, distributors, and regulatory bodies. Heightened awareness of cybersecurity threats and stringent data privacy regulations has prompted caution among industry players, leading to hesitancy in adopting digital solutions.

Product Traceability

The global demand for Digital Pharmaceutical Supply Chain Management is encountering challenges, notably a decrease attributed to concerns surrounding product traceability. While digital solutions offer advancements in tracking and visibility, there are apprehensions regarding the implementation of effective product traceability across the pharmaceutical supply chain. Product traceability is a critical aspect, ensuring the authenticity and safety of pharmaceuticals, yet the complexity of ensuring end-to-end traceability in a global supply chain introduces skepticism.

Pharmaceutical companies are navigating various regulatory landscapes, each with its own traceability requirements. Achieving standardization and interoperability across diverse systems remains a considerable hurdle, impacting the seamless implementation of digital solutions. Concerns about counterfeit drugs entering the supply chain and the ability to trace products back to their source are at the forefront, influencing the demand for Digital Pharmaceutical Supply Chain Management.

Interoperability

Interoperability refers to the ability of different software systems, applications, or devices to exchange and interpret data seamlessly and accurately. In the context of digital pharmaceutical supply chain management, interoperability presents a significant challenge due to the complexity of the supply chain ecosystem and the diverse technologies used by various stakeholders. The pharmaceutical supply chain involves multiple stakeholders, including manufacturers, distributors, wholesalers, pharmacies, healthcare providers, and regulatory agencies. Each of these stakeholders may use different software systems, data formats, and communication protocols. Achieving interoperability requires aligning these disparate systems and standards to ensure seamless data exchange and communication. Many pharmaceutical companies and supply chain partners rely on legacy systems that may not be compatible with modern digital technologies. Integrating these legacy systems with new digital solutions can be challenging and time-consuming, requiring custom development, data mapping, and middleware solutions to bridge the gap between old and new technologies.

Key Market Trends

Surge In Online Pharmacies

The global demand for Digital Pharmaceutical Supply Chain Management is experiencing a notable upswing, propelled by the surge in online pharmacies reshaping the pharmaceutical retail landscape. The rise of online pharmacies, driven by consumer preferences for convenient and accessible healthcare services, necessitates a more dynamic and digitally integrated supply chain. Digital Pharmaceutical Supply Chain Management becomes crucial in this context as it enables real-time visibility, traceability, and efficient distribution of pharmaceutical products.

Online pharmacies operate in a digital ecosystem where seamless coordination between suppliers, manufacturers, and distributors is paramount. Digital solutions facilitate accurate inventory management, order fulfillment, and timely delivery, meeting the demands of an increasingly digital and on-demand market. Ensuring the integrity and security of pharmaceutical products through the supply chain is vital, and digital technologies such as blockchain play a pivotal role in achieving transparency and trust in this evolving landscape.

Improved Demand Forecasting

The global demand for Digital Pharmaceutical Supply Chain Management is experiencing a considerable boost, driven by the imperative need for improved demand forecasting in the pharmaceutical industry. The ability to accurately predict and respond to market demands is critical, and digital solutions are proving instrumental in enhancing demand forecasting capabilities within the supply chain. Leveraging technologies such as advanced analytics, machine learning, and artificial intelligence, Digital Pharmaceutical Supply Chain Management enables pharmaceutical companies to analyze historical data, monitor real-time trends, and make data-driven predictions.

Improved demand forecasting helps streamline inventory management, reduce overstock or stockouts, and optimize the allocation of resources throughout the supply chain. The dynamic nature of the pharmaceutical market, coupled with factors such as product shelf life and regulatory compliance, emphasizes the importance of precision in forecasting.

Blockchain Technology

Blockchain is increasingly being adopted to create a secure and transparent supply chain ecosystem by recording transactions in a tamper-proof and decentralized manner. Blockchain technology provides a decentralized and tamper-proof ledger for recording transactions and tracking the movement of products throughout the supply chain. It enhances transparency, security, and trust among stakeholders by creating an immutable record of product provenance and authenticity.

Segmental Insights

Product Insights

Based on the product, in the global digital pharmaceutical supply chain management market, it is the software segment that held the dominant position in 2023. This is attributable to its pivotal role in streamlining and automating processes, enhancing efficiency, and reducing errors. Additionally, the growing need for compliance with regulations, coupled with the demand for real-time tracking and traceability, is driving the adoption of advanced software solutions in this sector.

The increasing complexity of pharmaceutical supply chains, coupled with stringent regulatory requirements and the need for greater transparency and traceability, has fuelled the demand for sophisticated software solutions. Pharmaceutical companies require robust digital tools to effectively manage and track the movement of products across multiple stakeholders, from manufacturers and distributors to healthcare providers and patients. Software solutions provide the necessary visibility and control to ensure compliance with regulatory standards, mitigate risks, and respond quickly to supply chain disruptions.

Furthermore, ongoing advancements in software technology, such as the adoption of cloud computing, artificial intelligence, machine learning, blockchain, and Internet of Things (IoT), are driving innovation in the digital pharmaceutical supply chain management market. These technologies enable the development of more intelligent, scalable, and interconnected software solutions that can address the evolving needs and challenges of the pharmaceutical industry.

Mode of Delivery Insights

Based on the mode of delivery segment, in the rapidly evolving global digital pharmaceutical supply chain management market, cloud-based solutions have emerged as dominant segment. These cutting-edge systems provide highly flexible, scalable, and easily accessible platforms that perfectly cater to the intricate and demanding needs of the pharmaceutical industry. One of the key advantages driving the widespread adoption of cloud-based solutions is the ability to seamlessly access real-time data from any location, empowering stakeholders with invaluable insights and enabling swift decision-making. This advantage sets cloud-based solutions apart from traditional on-premises and web-based alternatives, making them the preferred choice for forward-thinking pharmaceutical companies seeking to optimize their supply chain operations in today's dynamic landscape.

Regional Insights

North America dominated in the global digital pharmaceutical supply chain management market in 2023. This dominance is mainly attributed to the region's continuous technological advancements, well-established pharmaceutical and biotech industries, and a robust logistics and supply chain infrastructure. The convergence of these factors has created a favorable environment for the growth and innovation of digital solutions in managing the pharmaceutical supply chain. In addition to these factors, North America benefits from a highly skilled workforce, research and development capabilities, and a supportive regulatory framework. The region's strong focus on innovation and collaboration between industry stakeholders further propels its leadership position in the global digital pharmaceutical supply chain management market. Furthermore, North America's extensive network of healthcare providers, distribution channels, and advanced healthcare systems contribute to the seamless integration of digital technologies into the pharmaceutical supply chain. This integration enhances efficiency, reduces costs, and improves patient safety by ensuring the timely and accurate delivery of medications.

With North America leading the way, the region serves as a hub for knowledge exchange, fostering partnerships, and driving advancements in digital solutions for pharmaceutical supply chain management. As a result, it not only benefits the region but also influences the global landscape of the industry. North America's dominance in the Global Digital Pharmaceutical Supply Chain Management Market is a result of its continuous advancements, well-established industry, robust infrastructure, skilled workforce, supportive regulations, and collaborative ecosystem. This leadership position sets the stage for further advancements, innovation, and collaborations in the field, shaping the future of the pharmaceutical supply chain on a global scale.

Key Market Players

McKesson Corporation

Mediceo Corporation

Palantir Technologies, Inc.

InterSystems Corporation

Tecsys Inc.

Oracle Corporation

SAP SE

Infor Inc.

CenTrak, Inc. (HALMA plc)

Terso Solutions, Inc. (Promega Corporation)

Report Scope:

In this report, the Global Digital Pharmaceutical Supply Chain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Pharmaceutical Supply Chain Management Market,By Product:

• Software
• Hardware

Digital Pharmaceutical Supply Chain Management Market,By Mode of Delivery:

• On-premises
• Cloud-based
• Web-based

Digital Pharmaceutical Supply Chain Management Market,By Software Modules:

• Planning Analytics
• Procurement
• Manufacturing
• Logistics
• Inventory management

Digital Pharmaceutical Supply Chain Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pharmaceutical Supply Chain Management Market.

Available Customizations:

Global Digital Pharmaceutical Supply Chain Management market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Service Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Digital Pharmaceutical Supply Chain Management Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product (Software, Hardware)
  • 5.2.2.By Mode of Delivery (On-premises, Cloud-based, Web-based)
  • 5.2.3.By Software Modules (Planning Analytics, Procurement, Manufacturing, Logistics, Inventory management)
  • 5.2.4.By Region
  • 5.2.5.By Company (2023)
• 5.3.Market Map

6.North America Digital Pharmaceutical Supply Chain Management Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Product
  • 6.2.2.By Mode of Delivery
  • 6.2.3.By Software Modules
  • 6.2.4.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Digital Pharmaceutical Supply Chain Management Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product
      • 6.3.1.2.2.By Mode of Delivery
      • 6.3.1.2.3.By Software Modules
  • 6.3.2.Canada Digital Pharmaceutical Supply Chain Management Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product
      • 6.3.2.2.2.By Mode of Delivery
      • 6.3.2.2.3.By Software Modules
  • 6.3.3.Mexico Digital Pharmaceutical Supply Chain Management Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product
      • 6.3.3.2.2.By Mode of Delivery
      • 6.3.3.2.3.By Software Modules

7.Europe Digital Pharmaceutical Supply Chain Management Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product
  • 7.2.2.By Mode of Delivery
  • 7.2.3.By Software Modules
  • 7.2.4.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.France Digital Pharmaceutical Supply Chain Management Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product
      • 7.3.1.2.2.By Mode of Delivery
      • 7.3.1.2.3.By Software Modules
  • 7.3.2.Germany Digital Pharmaceutical Supply Chain Management Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product
      • 7.3.2.2.2.By Mode of Delivery
      • 7.3.2.2.3.By Software Modules
  • 7.3.3.United Kingdom Digital Pharmaceutical Supply Chain Management Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Product
      • 7.3.3.2.2.By Mode of Delivery
      • 7.3.3.2.3.By Software Modules
  • 7.3.4.Italy Digital Pharmaceutical Supply Chain Management Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product
      • 7.3.4.2.2.By Mode of Delivery
      • 7.3.4.2.3.By Software Modules
  • 7.3.5.Spain Digital Pharmaceutical Supply Chain Management Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product
      • 7.3.5.2.2.By Mode of Delivery
      • 7.3.5.2.3.By Software Modules

8.Asia-Pacific Digital Pharmaceutical Supply Chain Management Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product
  • 8.2.2.By Mode of Delivery
  • 8.2.3.By Software Modules
  • 8.2.4.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.India Digital Pharmaceutical Supply Chain Management Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product
      • 8.3.1.2.2.By Mode of Delivery
      • 8.3.1.2.3.By Software Modules
  • 8.3.2.Japan Digital Pharmaceutical Supply Chain Management Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product
      • 8.3.2.2.2.By Mode of Delivery
      • 8.3.2.2.3.By Software Modules
  • 8.3.3.South Korea Digital Pharmaceutical Supply Chain Management Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product
      • 8.3.3.2.2.By Mode of Delivery
      • 8.3.3.2.3.By Software Modules
  • 8.3.4.Australia Digital Pharmaceutical Supply Chain Management Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product
      • 8.3.4.2.2.By Mode of Delivery
      • 8.3.4.2.3.By Software Modules
  • 8.3.5.China Digital Pharmaceutical Supply Chain Management Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product
      • 8.3.5.2.2.By Mode of Delivery
      • 8.3.5.2.3.By Software Modules

9.South America Digital Pharmaceutical Supply Chain Management Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product
  • 9.2.2.By Mode of Delivery
  • 9.2.3.By Software Modules
  • 9.2.4.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Digital Pharmaceutical Supply Chain Management Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product
      • 9.3.1.2.2.By Mode of Delivery
      • 9.3.1.2.3.By Software Modules
  • 9.3.2.Argentina Digital Pharmaceutical Supply Chain Management Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product
      • 9.3.2.2.2.By Mode of Delivery
      • 9.3.2.2.3.By Software Modules
  • 9.3.3.Colombia Digital Pharmaceutical Supply Chain Management Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product
      • 9.3.3.2.2.By Mode of Delivery
      • 9.3.3.2.3.By Software Modules

10.Middle East and Africa Digital Pharmaceutical Supply Chain Management Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product
  • 10.2.2.By Mode of Delivery
  • 10.2.3.By Software Modules
  • 10.2.4.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Digital Pharmaceutical Supply Chain Management Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product
      • 10.3.1.2.2.By Mode of Delivery
      • 10.3.1.2.3.By Software Modules
  • 10.3.2.Saudi Arabia Digital Pharmaceutical Supply Chain Management Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product
      • 10.3.2.2.2.By Mode of Delivery
      • 10.3.2.2.3.By Software Modules
  • 10.3.3.UAE Digital Pharmaceutical Supply Chain Management Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product
      • 10.3.3.2.2.By Mode of Delivery
      • 10.3.3.2.3.By Software Modules

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Development (If Any)
• 12.2.Mergers Acquisitions (If Any)
• 12.3.Product/Service Launches (If Any)

13.Global Digital Pharmaceutical Supply Chain Management Market: SWOT Analysis

14.Porter's Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Products/Services

15.Competitive Landscape

• 15.1.McKesson Corporation
  • 15.1.1.Business Overview
  • 15.1.2.Company Snapshot
  • 15.1.3.Products Services
  • 15.1.4.Financials (As Reported)
  • 15.1.5.Recent Developments
  • 15.1.6.Key Personnel Details
  • 15.1.7.SWOT Analysis
• 15.2.Mediceo Corporation.
• 15.3.Palantir Technologies, Inc
• 15.4.InterSystems Corporation
• 15.5.Tecsys Inc.
• 15.6.Oracle Corporation
• 15.7.SAP SE
• 15.8.Infor Inc.
• 15.9.CenTrak Inc. (HALMA plc)
• 15.10. Terso Solutions, Inc. (Promega Corporation)

16.Strategic Recommendations

17.About Us Disclaimer